M65, ELISA Kit (96 tests)

データシート※最新のデータシートでない場合があります

• 商品コード：10020
• メーカー：PVV
• 包装：1kit
• 価格： ¥156,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  . [Social service in state mental hospitals]. SA Nurs J 1975 Mar;42(3):31
  
  1975/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 2
• 文献情報：
  H辰gg M et al. A novel high-through-put assay for screening of pro-apoptotic drugs. Invest New Drugs 2002 Aug;20(3):253-9
  H辰gg M et al
  2002/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 3
• 文献情報：
  Kramer G et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004 Mar;64(5):1751-6
  Kramer G et al
  2004/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 4
• 文献情報：
  Linder S et al. Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett. 2004 Oct;214(1):1-9
  Linder S et al
  2004/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 5
• 文献情報：
  Cummings J et al. Apoptosis pathway-targeted drugs--from the bench to the clinic. Biochim. Biophys. Acta 2004 Dec;1705(1):53-66
  Cummings J et al
  2004/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 6
• 文献情報：
  Erdal H et al. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2005 Jan;102(1):192-7
  Erdal H et al
  2005/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 7
• 文献情報：
  Kramer G et al. Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles. Br. J. Cancer 2006 Jun;94(11):1592-8
  Kramer G et al
  2006/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 8
• 文献情報：
  Cummings J et al. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br. J. Cancer 2006
  Cummings J et al
  2006/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 9
• 文献情報：
  Cummings J et al. Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother. Pharmacol. 2007 Nov;60(6):921-4
  Cummings J et al
  2007/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 10
• 文献情報：
  Yilmaz Y et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J. Gastroenterol. 2007 Feb;13(6):837-44
  Yilmaz Y et al
  2007/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 11
• 文献情報：
  Cummings J et al. Biomarker method validation in anticancer drug development. Br. J. Pharmacol. 2008 Feb;153(4):646-56
  Cummings J et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 12
• 文献情報：
  Klenk M et al. Streptococcus pyogenes serotype-dependent and independent changes in infected HEp-2 epithelial cells. ISME J 2007 Dec;1(8):678-92
  Klenk M et al
  2007/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 13
• 文献情報：
  Carpinelli P et al. Aurora kinase inhibitors: identification and preclinical validation of their biomarkers. Expert Opin. Ther. Targets 2008 Jan;12(1):69-80
  Carpinelli P et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 14
• 文献情報：
  Greystoke A et al. Optimisation of circulating biomarkers of cell death for routine clinical use. Ann. Oncol. 2008 May;19(5):990-5
  Greystoke A et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 15
• 文献情報：
  Krysko DV et al. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 2008 Mar;44(3):205-21
  Krysko DV et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 16
• 文献情報：
  Cummings J et al. Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity. Mol. Cancer Ther. 2008 Mar;7(3):455-63
  Cummings J et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 17
• 文献情報：
  Volkmann X et al. Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 2008 May;47(5):1624-33
  Volkmann X et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 18
• 文献情報：
  Bechmann LP et al. Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure. Liver Int. 2008 May;28(5):713-6
  Bechmann LP et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 19
• 文献情報：
  Cavarretta IT et al. Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma. Adv. Exp. Med. Biol. 2008;617:547-55
  Cavarretta IT et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 20
• 文献情報：
  Younossi ZM et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008 Nov;18(11):1430-7
  Younossi ZM et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 21
• 文献情報：
  de Haas EC et al. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer. Neoplasia 2008 Oct;10(10):1041-8
  de Haas EC et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 22
• 文献情報：
  Micha D et al. Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer. Clin. Cancer Res. 2008 Nov;14(22):7304-10
  Micha D et al
  2008/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 23
• 文献情報：
  Fisher MB et al. Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker. Cancer Gene Ther. 2009 Jul;16(7)
  Fisher MB et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 24
• 文献情報：
  Ozturk B et al. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. Int. Immunopharmacol. 2009 May;9(5):645-8
  Ozturk B et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 25
• 文献情報：
  Koelink PJ et al. Circulating cell death products predict clinical outcome of colorectal cancer patients. BMC Cancer 2009;9:88
  Koelink PJ et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 26
• 文献情報：
  Hofer S et al. Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 2009;13(3):R93
  Hofer S et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 27
• 文献情報：
  Scott LC et al. Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response. Br. J. Cancer 2009 Aug;101(3):410-7
  Scott LC et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 28
• 文献情報：
  Hou JM et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am. J. Pathol. 2009 Aug;175(2):808-16
  Hou JM et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 29
• 文献情報：
  Bantel H et al. Cell death in sepsis: a matter of how, when, and where. Crit Care 2009;13(4):173
  Bantel H et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 30
• 文献情報：
  Ausch C et al. Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients. J. Gastrointest. Surg. 2009 Nov;13(11):2020-6
  Ausch C et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 31
• 文献情報：
  Jochum C et al. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 2009;80(4):235-40
  Jochum C et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 32
• 文献情報：
  Cave M et al. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology 2010 Feb;51(2):474-81
  Cave M et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 33
• 文献情報：
  Kahraman A et al. Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 2010 Jan;51(1):92-102
  Kahraman A et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 34
• 文献情報：
  Ulukaya S et al. Soluble cytokeratin 18 biomarkers may provide information on the type of cell death during early ischemia and reperfusion periods of liver transplantation. Clin Transplant 2010 Nov;24(6):848-54
  Ulukaya S et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 35
• 文献情報：
  Dive C et al. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. Br. J. Cancer 2010 Feb;102(3):577-82
  Dive C et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 36
• 文献情報：
  Tsutsui M et al. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels. J. Clin. Gastroenterol. 2010 Jul;44(6):440-7
  Tsutsui M et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 37
• 文献情報：
  Paschos KA et al. Corticotropin-releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis. Endocrinology 2010 Apr;151(4):1704-12
  Paschos KA et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 38
• 文献情報：
  Brandt D et al. Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas. Eur. J. Cancer 2010 May;46(8):1464-73
  Brandt D et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 39
• 文献情報：
  Yaman E et al. Serum M30 levels are associated with survival in advanced gastric carcinoma patients. Int. Immunopharmacol. 2010 Jul;10(7):719-22
  Yaman E et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 40
• 文献情報：
  Linder S et al. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies. Expert Rev. Mol. Diagn. 2010 Apr;10(3):353-9
  Linder S et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 41
• 文献情報：
  Sarker D et al. Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development. Biomark Med 2007 Oct;1(3):399-417
  Sarker D et al
  2007/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 42
• 文献情報：
  Linder S et al. Serum efficacy biomarkers for oncology. Biomark Med 2009 Feb;3(1):47-54
  Linder S et al
  2009/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 43
• 文献情報：
  Younossi ZM et al. A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis. Obes Surg 2011 Apr;21(4):431-9
  Younossi ZM et al
  2011/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 44
• 文献情報：
  Samuel D et al. Prognosis indicator in acute liver failure: Is there a place for cell death markers? J. Hepatol. 2010 Oct;53(4):593-5
  Samuel D et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 45
• 文献情報：
  Bechmann LP et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J. Hepatol. 2010 Oct;53(4):639-47
  Bechmann LP et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 46
• 文献情報：
  Dech棚ne A et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 2010 Sep;52(3):1008-16
  Dech棚ne A et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 47
• 文献情報：
  Lickliter JD et al. Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. Br. J. Cancer 2010 Aug;103(5):597-606
  Lickliter JD et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 48
• 文献情報：
  De Petris L et al. Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer. Eur. J. Cancer 2011 Jan;47(1):131-7
  De Petris L et al
  2011/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 49
• 文献情報：
  Bilici A et al. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer? Cancer Chemother. Pharmacol. 2010 Oct;
  Bilici A et al
  2010/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 50
• 文献情報：
  Schlienger M et al. [Radiosurgical irradiation of 49 cerebral arteriovenous malformations using linear accelerator]. Bull Cancer Radiother 1994;81(2):99-109
  Schlienger M et al
  1994/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：
  

• No.： 51
• 文献情報：
  Elliott AM et al. Developmental anomalies suggestive of the human homologue of the mouse mutant disorganization. Am. J. Med. Genet. 1995 Jan;55(2):240-3
  Elliott AM et al
  1995/01/01
  
• 備考：
  Sample species: H. sapiens
• 参照：